Janus Henderson Investors US’s Pediatrix Medical MD Stock Holding History

Janus Henderson Investors US’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.12M	Sell	16,195 -9,738	-38%	-$676K	﹤0.01%	991
2016 Q4	$1.73M	Sell	25,933 -70,995	-73%	-$4.62M	﹤0.01%	985
2016 Q3	$6.42M	Sell	96,928 -65,814	-40%	-$4.5M	0.01%	777
2016 Q2	$11.8M	Sell	162,742 -685,599	-81%	-$47.1M	0.01%	645
2016 Q1	$54.8M	Sell	848,341 -16,062	-2%	-$1.07M	0.05%	406
2015 Q4	$61.9M	Sell	864,403 -18,103	-2%	-$1.34M	0.05%	366
2015 Q3	$67.8M	Sell	882,506 -141,208	-14%	-$11.4M	0.06%	361
2015 Q2	$75.9M	Buy	1,023,714 +106,899	+12%	+$7.69M	0.06%	358
2015 Q1	$66.5M	Buy	916,815 +200,167	+28%	+$13.9M	0.05%	386
2014 Q4	$47.4M	Sell	716,648 -99,781	-12%	-$6.09M	0.04%	456
2014 Q3	$44.8M	Buy	816,429 +121,821	+18%	+$6.91M	0.04%	443
2014 Q2	$40.4M	Buy	694,608 +124,900	+22%	+$7.35M	0.04%	455
2014 Q1	$35.3M	Buy	569,708 +216,563	+61%	+$12.6M	0.03%	462
2013 Q4	$18.9M	Buy	353,145 +44,703	+14%	+$2.4M	0.02%	546
2013 Q3	$15.5M	Buy	308,442 +2,980	+1%	+$145K	0.02%	576
2013 Q2	$14M	Buy	+305,462	New	+$13.7M	0.01%	564

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Janus Henderson Investors US's MD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Pediatrix Medical (MD) stake by 38% in Q1 2017, selling an estimated $676K and leaving 16,195 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Janus Henderson Investors US first reported a position in MD in Q2 2013 and has held it in 16 quarters since. The position peaked at $75.9M in Q2 2015. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

Janus Henderson Investors US held 16,195 shares of Pediatrix Medical worth $1.12M as of Q1 2017.
Janus Henderson Investors US sold 9,738 Pediatrix Medical shares in Q1 2017, an estimated $676K.
Pediatrix Medical made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #991 holding.
Janus Henderson Investors US first reported a position in Pediatrix Medical in Q2 2013 and has held it in 16 quarters since.
Janus Henderson Investors US's Pediatrix Medical position peaked at $75.9M in Q2 2015.
359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.